BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 26816105)

  • 1. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.
    Enders F; Geisenberger C; Jungk C; Bermejo JL; Warta R; von Deimling A; Herold-Mende C; Unterberg A
    Clin Neurol Neurosurg; 2016 Mar; 142():72-80. PubMed ID: 26816105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Metastases of Non-Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection.
    Antuña AR; Vega MA; Sanchez CR; Fernandez VM
    J Neurol Surg A Cent Eur Neurosurg; 2018 Mar; 79(2):101-107. PubMed ID: 28586934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.
    Pessina F; Navarria P; Cozzi L; Tomatis S; Ascolese AM; Franzese C; Toschi L; Santoro A; De Rose F; Franceschini D; Bello L; Scorsetti M
    Br J Radiol; 2017 Apr; 90(1072):20170022. PubMed ID: 28256924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
    She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
    Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control.
    Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
    J Neurosurg; 2002 Dec; 97(6):1276-81. PubMed ID: 12507123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases].
    Kudelin N; Bölükbas S; Schirren J
    Zentralbl Chir; 2015 Jun; 140(3):328-33. PubMed ID: 26114639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.
    Hendriks LE; Troost EG; Steward A; Bootsma GP; De Jaeger K; van den Borne BE; Dingemans AM
    Acta Oncol; 2014 Jul; 53(7):945-51. PubMed ID: 24754845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
    Bernhardt D; König L; Aufderstrasse S; Krisam J; Hoerner-Rieber J; Adeberg S; Bozorgmehr F; El Shafie R; Lang K; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Marcrom S; Debus J; Steins M; Rieken S
    Clin Lung Cancer; 2018 Jul; 19(4):340-345. PubMed ID: 29373273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of brain metastases from non-small cell lung cancer.
    Baykara M; Kurt G; Buyukberber S; Demirci U; Ceviker N; Algin E; Coskun U; Aykol S; Emmez H; Ozet A; Benekli M
    J Cancer Res Ther; 2014; 10(4):915-21. PubMed ID: 25579528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
    Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
    BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for patients with microsurgically resected brain metastases.
    Korinth MC; Delonge C; Hütter BO; Gilsbach JM
    Onkologie; 2002 Oct; 25(5):420-5. PubMed ID: 12415195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
    Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma knife radiosurgery in non small cell lung cancer patients with brain metastases: treatment results and prognostic factors.
    Abacioglu U; Caglar H; Atasoy BM; Abdulloev T; Akgun Z; Kilic T
    J BUON; 2010; 15(2):274-80. PubMed ID: 20658721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of prognostic factors in NSCLC patients with brain metastases 
diagnosed by constrast-enhanced MRI after whole brain radiotherapy].
    Liu H; Wu Q; Gong X; He X; Wu H; Sheng Z; Zhou D
    Zhongguo Fei Ai Za Zhi; 2011 Sep; 14(9):719-22. PubMed ID: 21924038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.